Search results
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 9 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 12 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
CBS 47 Fresno· 15 hours ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 15 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WHTC 1450 Holland· 15 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher...
Medical Xpress· 1 day agoThis EU announcement was preceded by an application from AstraZeneca on March 27, 2024, to withdraw...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 2 days ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products. AstraZeneca is...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 2 days agoThe reason Novavax's stock chart looks so wild has to do with its promise and missed opportunity...
